GeneTex
  • Country / Location Selection

United States (US)

BCL3 blocking peptide

Cat No. GTX31868-PEP

Application

Neutralizing/Inhibition
Package
50 μg ($139)
PRODUCT

Summary

BCL3 peptide is used for blocking the activity of BCL3 antibody (catalog number GTX31868).

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
Neutralizing/Inhibition Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl), 0.1% BSA, 0.02% sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

B Cell Cll/Lymphoma 3 , Bcl4 , D19S37 , Bcl3

Background

This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B. [provided by RefSeq, Jul 2008]

Research Area

REFERENCE

There are currently no references for BCL3 blocking peptide (GTX31868-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for BCL3 blocking peptide (GTX31868-PEP). Be the first to share your experience with this product.
SDS
PBS.pdf
Sodium Azide.pdf
Package List Price ($)
$ 139